SCHEMBL28023618

SCHEMBL28023618

CCN1CCN(Cc2ccc(Nc3cc(NC(=O)Nc4c(Cl)cccc4Cl)ncn3)cc2)CC1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 5/20 0.59
EGFR P00533 4/20 0.59
ABL1 P00519 2/20 0.59
KIT P10721 2/20 0.59
SRC P12931 2/20 0.59
BRAF P15056 2/20 0.59
KDR P35968 2/20 0.59
TEK Q02763 2/20 0.59
PDGFRB P09619 1/20 0.59
EPHB4 P54760 1/20 0.59
RAB9A P51151 5/20 0.55
NPC1 O15118 4/20 0.55
TP53 P04637 3/20 0.55
SMN1; SMN2 Q16637 3/20 0.55
POLB P06746 1/20 0.53
FGFR3 P22607 4/20 0.49
LMNA P02545 1/20 0.47
MAPT P10636 1/20 0.47
ALOX15 P16050 2/20 0.47
CYP1A2 P05177 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28023995 0.92 FGFR1 (0.50) FGFR1EGFRABL1KITSRC
SCHEMBL374657 0.92 FGFR3 (0.58) FGFR1EGFRABL1KITSRC
SCHEMBL374228 0.87 LCK (0.57) FGFR1EGFRABL1KITSRC
SCHEMBL15295501 0.86 FGFR3 (0.59) FGFR1EGFRABL1KITSRC
SCHEMBL373374 0.85 FGFR3 (0.56) FGFR1EGFRABL1KITSRC
SCHEMBL28821018 0.80 ABL1 (0.49) FGFR1EGFRABL1KITSRC
SCHEMBL374526 0.79 EGFR (0.69) FGFR1EGFRABL1KITSRC
SCHEMBL374009 0.78 FGFR3 (0.75) FGFR1EGFRABL1KITSRC
SCHEMBL374328 0.78 EGFR (0.74) FGFR1EGFRABL1KITSRC
SCHEMBL374474 0.78 METTL3 (0.47) FGFR1EGFRABL1KITSRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103121972-B As the pyrimidine urea derivatives of kinase inhibitor NOVARTIS AG (CH) 2015-07-29 CN claimed